Reckitt Benckiser launches Gaviscon

The heartburn reflux medicine is expected to strengthen its healthcare portfolio.


New Delhi, November 14, 2013: Reckitt Benckiser has launched heartburn (acidity) reflux medicine Gavison nationally with a view to strengthen its healthcare portfolio.


The company said that its focus is to further build and strengthen its healthcare portfolio and the launch of Gaviscon is towards that goal.


It may be noted here that Gaviscon is amongst the 19 power brands in the Reckitt Benckiser portfolio and the company plans to support the launch with a strong detailing outreach across the 40 key cities of India. 


* Indicates mandatory field.
Please wait while comments are being sent...